Nextgen Biomed Ltd (TLV:NXGN)
48.70
+0.30 (0.62%)
At close: Sep 30, 2025
Nextgen Biomed Market Cap
Nextgen Biomed has a market cap or net worth of 7.21 million as of December 19, 2025. Its market cap has increased by 10.23% in one year.
Market Cap
7.21M
Enterprise Value
7.27M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
48.70
Market Cap Chart
Since July 17, 2013, Nextgen Biomed's market cap has decreased from 18.97M to 7.21M, a decrease of -62.01%. That is a compound annual growth rate of -7.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 7.21M | 10.19% |
| Dec 31, 2024 | 6.54M | -28.83% |
| Dec 31, 2023 | 9.19M | -66.19% |
| Dec 29, 2022 | 27.18M | -55.05% |
| Dec 30, 2021 | 60.47M | -24.05% |
| Dec 31, 2020 | 79.61M | 936.11% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 111.54B |
| Danel (Adir Yeoshua) | 2.75B |
| Kamada | 1.38B |
| BrainsWay | 1.04B |
| Bait Bakfar | 1.03B |
| SofWave Medical | 999.21M |
| Ilex Medical | 737.86M |
| Novolog (Pharm-Up 1966) | 650.34M |